Mark Sullivan, PharmD, MBA, BCPS, has been promoted from associate chief pharmacy officer to chief pharmacy officer.
Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights.
Cancer therapies that target VEGF receptor appear safe and effective for patients with pancreatic and non-pancreatic neuroendocrine tumors, meta-analysis of phase 2/3 clinical trials demonstrates.
Vanderbilt University Medical Center to be an early adopter as a hospital system integrating the Tennessee Advanced Communications Network into its existing network of emergency providers for redundancy communications in the event of a disaster.
Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery.